2023 Fall Conference: Losing our Mind and Finding It: Re-Integrating Meaning in a Neurobiologically-Focused Era
A Conference for Psychiatric Care Providers, Psychotherapists, and Social Scientists
Despite our burgeoning neuroscientific knowledge, psychiatric outcomes are not significantly better than they were three decades ago. After decades of hopeful enthusiasm, the limits of a biomedically-reductionist approach to problems of mental health are increasingly clear. A renewed interest in integrating biomedical and psychosocial perspectives to optimize mental health outcomes is gaining momentum, whether in a focus on patient-centeredness, the development of collaborative care models, increasing attention to the social determinants of mental health, or efforts to re-integrate psychodynamic with medical approaches.
This conference will explore areas where bio and psycho and social intersect, and will examine the utility of interdisciplinary engagement. This conference will ask the question of what medications are, beyond simple biological treatments. Foci will include the limits of reductionist approaches, sociological perspectives on contemporary psychiatric care, psychodynamic aspects of health equity, the psychotherapeutic value of exploring the psychological functions of medications, and the value, in pharmacotherapy, of integrating focused psychodynamic techniques. Intended outcomes are that conference participants should have increased knowledge and skills for working at the boundaries between disciplines, that psychiatric prescribers should be better equipped to address the meaning dimension in pharmacotherapy, and that psychotherapists should enhance their skills in exploring medications as important psychological phenomena.
Conference cost: $125
Student/Trainee: $25 (use coupon code TRAINEE)
Scholarships are available--please contact the Erikson Institute for information
SCHEDULE (subject to change)
Friday, October 13, 2023
10:00-10:30 a.m. David Mintz, MD: Conference Opening
Thinking About Mental Illness
10:30-11:20 a.m. Tanya Luhrmann, PhD: “Of Two Minds, 30 Years Later”
11:20-11:30 a.m. Q & A
11:30 a.m.-12:20 p.m. Awais Aftab, MD: “Fault Lines in Biopsychosocial Psychiatry: Integrative Aspirations and the Path Forward”
12:20-12:30 p.m. Q & A
12:30-1:00 p.m. Lunch
1:00-1:50 p.m. Nancy McWilliams, PhD, ABPP: “Diagnosis and its Discontents”
1:50-2:00 p.m. Q & A
2:00-2:30 p.m. Morning Panel Discussion
2:30-2:40 p.m. Break
Meaning & Medication
2:40-3:30 p.m. Kathryn T. Hall, PhD: “Meaning Effects and Health Equity”
3:30-3:40 p.m. Q & A
3:40-4:30 p.m. Kyle Shepard, DO: “Meaning & Medication: The Evidence Base”
4:30-4:40 p.m. Q & A
4:40-5:10 p.m. Friday Panel Discussion
Saturday, October 14, 2023
10:00-10:10 a.m. Conference Opening–Day 2
Psychodynamic Technique in Pharmacotherapy
10:10-11:00 a.m. David Mintz, MD: “Psychodynamic Psychopharmacology”
11:00-11:10 a.m. Q & A
11:10 a.m.-12:00 p.m. Haroula Konstantinidou, MBBS: “Challenges of Integrating Pharmacotherapy and Psychodynamics”
12:00-12:10 p.m. Q & A
12:10-12:45 p.m. Morning Panel Discussion
12:45-1:15 p.m. Lunch
Pharmacotherapy as a Psychotherapeutic Focus
1:15-2:05 p.m. Alicia Powell, MD: “The Medication Life”
2:05-2:15 p.m. Q & A
2:15-3:05 p.m. Adele Tutter, MD: “Medication as Object”
3:05-3:15 p.m. Q & A
3:15-3:45 p.m. Afternoon Panel Discussion
3:45-4:30 p.m. Conference Panel Discussion and Closing (all presenters & audience)
- Describe how biomedical reductionist approaches unhelpfully restrict our ways of understanding and addressing patients;
- Identify ways that the meaning of medications may harm patients and contribute to the problem of health inequity;
- Describe how pharmacologic treatment effects are profoundly shaped by a wide range of psychological and social factors;
- Implement a model treatment that addresses the meaning of medications and enhances the prescriber-patient alliance in ways that support the patient’s authority;
- Anticipate and address issues in the system and interprofessional team in relation to an integrated approach to pharmacotherapy;
- Psychotherapeutically explore the meanings of medications in ways that benefit the patient and support interprofessional collaboration.
Awais Aftab, MD, is a psychiatrist and clinical assistant professor of psychiatry at Case Western Reserve University, Cleveland, Ohio, USA. He leads the popular interview series “Conversations in Critical Psychiatry” for Psychiatric Times, which engages with prominent commentators within and outside the profession who have made meaningful criticisms of the status quo. He is currently working on a book adaptation of the interview series for Oxford University Press (2023).
Haroula Konstantinidou, MD, MRCPsych, is a consultant medical psychotherapist working with complex emotional presentations (personality disorder, complex trauma, treatment resistant depression) across a number of pathways. She is the psychotherapy tutor coordinating training and psychotherapy placements for core and higher trainees and she runs reflective practice groups. Her research interests include integrating psychotherapeutic approaches in general psychiatry and relational aspects of prescribing practices.
Tanya Marie Luhrmann, PhD, is the Albert Ray Lang Professor of Anthropology at Stanford University, with a courtesy appointment in psychology. Her work focuses on the edge of experience: on voices, visions, the world of the supernatural and the world of psychosis. She has done ethnography on the streets of Chicago with homeless and psychotic women, and worked with people who hear voices in Chennai, Accra and the South Bay. She has also done fieldwork with evangelical Christians who seek to hear God speak back, with Zoroastrians who set out to create a more mystical faith, and with people who practice magic. She uses a combination of ethnographic and experimental methods to understand the phenomenology of unusual sensory experiences, the way they are shaped by ideas about minds and persons, and what we can learn from this social shaping that can help us to help those whose voices are distressing. At the heart of the work is the sense of being called, and its possibilities and burden.
She was named to the American Academy of Arts and Sciences in 2003, received a John Guggenheim Fellowship award in 2007 and elected to the American Philosophical Society in 2022. When God Talks Back was named a NYT Notable Book of the Year and a Kirkus Reviews Best Book of the Year. It was awarded the $100,000 Grawemeyer Prize for Religion by the University of Louisville. She has published over thirty OpEds in The New York Times, and her work has been featured in The New Yorker, The New York Review of Books, The Times Literary Supplement, Science News, and many other publications. She is the author of Persuasions of the Witch’s Craft, The Good Parsi, Of Two Minds, When God Talks Back, Our Most Troubling Madness, and How God Becomes Real, and is currently at work on a book entitled Voices.
Kathryn T. Hall, PhD, received her PhD in microbiology and molecular henetics from Harvard University before spending 10 years in the biotech industry tackling problems in drug development, first at Wyeth and then at Millennium Pharmaceuticals, where she became an associate director of drug development. Dr. Hall returned to HMS in 2010, joining the Fellowship in Integrative Medicine at Beth Israel Deaconess Medical Center (BIDMC) in 2012, and receiving a Master’s in Public Health from Harvard School of Public Health in 2014.
In collaboration with Professor Ted Kaptchuk and other members of the Program in Placebo Studies at HMS, Dr. Hall’s recent research has focused on catechol-O-methyltransferase (COMT), an enzyme that metabolizes catecholamines such as dopamine and epinephrine and that has pleiotropic effects in a broad set of diseases and treatments. Among her recent accomplishments is a landmark paper published in PLOS ONE identifying COMT as one of the first genetic markers of placebo response, and a broader review in Trends in Molecular Medicine on the impact of genetics on the placebo response. Her work has led to the coining of the term “placebome”, which was added to Jargonwatch by WIRED magazine in 2015. Her research has been the focus of numerous articles including features in Science, The Atlantic, The Economist, and Discover magazines.
Alicia Powell, MD, (she/her) is the assistant medical director at Vinfen, a nonprofit health and human services organization providing community-based services to individuals with mental health conditions, intellectual and developmental disabilities, brain injuries, and behavioral health challenges. She also maintains a private practice in Boston.
Adele Tutter, MD, PhD,. is associate clinical professor of psychiatry, Columbia University; faculty, the Center for Psychoanalytic Training and Research; and director, the Psychoanalytic Studies Program of the Graduate School of Arts and Sciences. She is also faculty, the New York Psychoanalytic Institute. Her interdisciplinary scholarship has earned the American Psychoanalytic Association Menninger, CORST, and Ticho prizes, among others. Dr. Tutter is coeditor (with Leon Wurmser), Grief and its Transcendence: Memory, Identity, and Creativity (Routledge, 2015); editor, The Muse: Psychoanalytic Explorations of Creative Inspiration (Routledge, 2016); and author, Dream House: An Intimate Portrait of the Philip Johnson Glass House (University of Virginia Press, 2016). Currently completing a second monograph, Mourning and Metamorphosis: Poussin’s Ovidian Vision, she sits on the editorial boards of The International Journal of Psychoanalysis, Psychoanalytic Quarterly, and American Imago. She is a regular contributor of art criticism to the Brooklyn Rail and maintains a private practice in Manhattan.
Kyle Shepard, DO, is a Fellow in hospital-based psychotherapy and psychoanalytic studies at the Austen Riggs Center. Before starting at the Austen Riggs Center he worked as an inpatient attending physician at the Institute of Living where he had the pleasure of teaching medical students, psychiatry residents, and psychology trainees.
David Mintz, MD, is a staff psychiatrist who joined the Austen Riggs Center in 1996. He presently serves as the director of psychiatric education, the associate director of training, and as a team leader. He also is principal investigator for the research initiative in Psychodynamic Psychopharmacology and author of the book Psychodynamic Psychopharmacology: Caring for the Treatment-Resistant Patient (2022, American Psychiatric Association Publishing). Dr. Mintz also coordinates the Elective in Psychodynamic Psychiatry at the Austen Riggs Center.
Nancy McWilliams, PhD, teaches at Rutgers University’s Graduate School of Applied & Professional Psychology and practices in Lambertville, New Jersey. She is author of Psychoanalytic Diagnosis (1994, rev. ed. 2011), Psychoanalytic Case Formulation (1999), Psychoanalytic Psychotherapy (2004), and Psychoanalytic Supervision (2021) and is associate editor of both editions of the Psychodynamic Diagnostic Manual (2006, 2017). A former president of Division 39 (Psychoanalysis) of the American Psychological Association, she has been featured in three APA videos of master clinicians. She is on the Board of Trustees of the Austen Riggs Center. Her books are available in 20 languages; she lectures widely both nationally and internationally.
Austen Riggs Center Inc. adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. All those at Austen Riggs Center involved in the planning of this activity, including the presenter(s) listed above, report they have no relevant financial relationships with an ineligible company*.
The views and opinions expressed in this presentation are those of the presenter(s) and do not necessarily represent the official policy or position of the Austen Riggs Center.
* An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients
The Austen Riggs Center designates this live interactive webinar for a maximum of 11.00 AMA PRA Category1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Austen Riggs Center is accredited by the Massachusetts Medical Society to provide continuing medical education for physicians.
The Austen Riggs Center’s policy on disclosure, in keeping with requirements of the Massachusetts Medical Society, requires continuing education planners and speakers to disclose any relevant financial interest or other relationship with commercial entities that could pose a potential conflict of interest in the presentation of this educational activity. The Austen Riggs Center Continuing Medical Education Committee has established policies for identifying and resolving all conflicts of interest prior to this educational activity. The Austen Riggs Center accepts no commercial support of any kind to support our CME/CE activity.
The Austen Riggs Center also designates this live interactive webinar for 11.00 continuing education credit(s) (CE) for psychology.
Austen Riggs Center, Inc. is recognized by the New York State Education Department’s State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0115.
The Austen Riggs Center is approved by the American Psychological Association to sponsor continuing education for psychologists. The Austen Riggs Center maintains responsibility for the program and its content.
The Austen Riggs Center, #1344, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Austen Riggs Center maintains responsibility for this course. ACE provider Approval Period: 02/02/2023-2/2/2026. Social workers completing this live interactive webinar will receive 11.00 continuing education credits.
For a listing of jurisdictions that accept ACE, please visit www.aswb.org/ace/ace-jurisdiction-map/.
- 11.00 AMA PRA Category 1 Credit™Austen Riggs Center,Inc. is accredited by the Massachusetts Medical Society to provide continuing medical education for physicians. Austen Riggs Center, Inc. designates this Live for a maximum of 11.00 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 11.00 APAThe Austen Riggs Center, Inc. designates this live interactive webinar for 11.00 continuing education credit(s) (CE) for psychology. The Austen Riggs Center is approved by the American Psychological Association to sponsor continuing education for psychologists. The Austen Riggs Center maintains responsibility for the program and its content.
- 11.00 ASWB-ACEThe Austen Riggs Center, #1344, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Austen Riggs Center maintains responsibility for this course. ACE provider Approval Period: 02/02/2020-2/2/2023. Social workers completing this live interactive webinar will receive 11.00 continuing education credit(s). For a listing of jurisdictions that accept ACE, please visit States and provinces that accept ACE | Association of Social Work Boards .
- 11.00 Contact Hours/ Participation